|
⚲
|
| Keyboard |
| Lynch Ryan
✚
|
|
|---|---|
| CIK # | 0001709271 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001709271] | |
| 4 | [0001709271] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Lynch Ryan | |
| Crescent Biopharma Inc | |
| Concert Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Crescent Biopharma Inc CBIO
Stock Option (Right to Buy) · derivative
|
2025-12-15 | Grant | 33,512 | $0.00 | |
|
Crescent Biopharma Inc CBIO
Ordinary Shares
|
2025-12-15 | Grant | 4,000 | ||
|
Crescent Biopharma Inc CBIO
Ordinary Shares
|
2025-12-15 | Grant | 8,378 | ||
|
Concert Pharmaceuticals Inc CNCE
Common Stock
|
2019-08-15 | Grant | 14,063 | ||
|
Concert Pharmaceuticals Inc CNCE
Common Stock
|
2019-03-31 | Tax withheld | 1,043 | $12.07 | 12,589 |
|
Concert Pharmaceuticals Inc CNCE
Employee Stock Option (right to buy) · derivative
|
2019-01-04 | Grant | 6,100 | $0.00 | |
|
Concert Pharmaceuticals Inc CNCE
Common Stock
|
2018-03-31 | Tax withheld | 961 | $22.90 | 22,007 |
|
Concert Pharmaceuticals Inc CNCE
Employee Stock Option (right to buy) · derivative
|
2018-01-04 | Grant | 4,950 | $0.00 | |
|
Concert Pharmaceuticals Inc CNCE
Employee Stock Option (right to buy) · derivative
|
2017-09-14 | Option exercise | 3,500 | $0.00 | |
|
Concert Pharmaceuticals Inc CNCE
Common Stock
|
2017-09-14 | Sell | 3,500 | $14.51 | 50,785 |
|
Concert Pharmaceuticals Inc CNCE
Common Stock
|
2017-09-14 | Option exercise | 3,500 | $9.46 | 33,110 |
|
Concert Pharmaceuticals Inc CNCE
Common Stock
|
2017-07-06 | Grant | 6,000 |